Table 2

Prevalence (%) of clusters of symptoms during high and low exposure for both exposed (n=259) and control subjects (n=149)

Symptom High exposure
period
Low exposure
period
Skin or extremities (⩾3/8):
 Exposed12.414.3
 Control10.111.4
Respiratory (⩾3/7):
 Exposed19.314.7
 Control5.414.8
Systemic (⩾3/8):
 Exposed15.112.4
 Control8.111.4
Eye (⩾2/2):
 Exposed10.05.0
 Control4.77.4
CNS (⩾5/14):
 Exposed19.717.4
 Control8.717.4